Evaluation of the safety and effectiveness of oral propranolol in patients with von Hippel-Lindau disease and retinal hemangioblastomas: phase III clinical trial

por González-Rodríguez, Beatriz, Villar Gómez de las Heras, Karina, Aguirre, Daniel T, Rodríguez-Padial, Luis, Albiñana, Virginia, Recio-Poveda, Lucía, Cuesta, Angel M, Botella, Luisa Mª, Jiménez-Escribano, Rosa María
Publicado 2019